Enrofloxacin is a broad-spectrum antibacterial agent belonging to the fluoroquinolone family of antibiotics. It was developed specifically for veterinary medicine and is widely used in livestock, poultry and aquaculture. Enrofloxacin is also known as ethyl ciprofloxacin because its molecular structure is closely related to ciprofloxacin, and it carries the CAS number 93106-60-6.
What Is Enrofloxacin?
Enrofloxacin is a synthetic fluoroquinolone antibiotic formulated for animal health applications. It is available in oral and injectable dosage forms depending on the target species and regulatory approval. The compound is characterised by a long elimination half-life and excellent tissue distribution, which allows it to reach therapeutic concentrations in organs and tissues affected by bacterial infection.
How Enrofloxacin Works
Enrofloxacin exerts its bactericidal effect by inhibiting bacterial DNA gyrase, also known as topoisomerase II. This enzyme is essential for the replication, transcription and repair of bacterial DNA. When DNA gyrase is blocked, bacterial cells can no longer replicate their genetic material, and the bacteria die. Because the mechanism targets a bacterial-specific enzyme, fluoroquinolones show selective toxicity towards bacteria rather than host cells.
Antibacterial Spectrum of Enrofloxacin
Enrofloxacin has a broad spectrum of activity covering many Gram-negative and Gram-positive pathogens. It is particularly effective against Mycoplasma species, which are common in respiratory disease complexes of poultry and swine. Other susceptible organisms include Escherichia coli, Klebsiella pneumoniae, Salmonella species, Proteus species, Pseudomonas aeruginosa, Haemophilus species, Staphylococcus aureus and Pasteurella species.
Approved Veterinary Applications
In veterinary practice, enrofloxacin is used to treat bacterial infections in poultry, swine, cattle and companion animals, as well as in aquaculture. Typical indications include respiratory tract infections, colibacillosis, salmonellosis and other systemic bacterial diseases. The product must be used strictly according to the approved label and under veterinary supervision, with attention to withdrawal periods so that residues do not enter the food chain.
Responsible Use and Regulatory Considerations
Enrofloxacin is intended for animals only and must never be used in humans. Misuse of fluoroquinolones contributes to antimicrobial resistance, which is a growing concern in both human and veterinary medicine. To preserve the effectiveness of the drug class, treatment should be based on a confirmed bacterial diagnosis, correct dosing according to the label, and completion of the full prescribed course. Local regulations on prescription status, withdrawal times and record keeping must be followed.
Frequently Asked Questions
Is enrofloxacin the same as ciprofloxacin? They are closely related fluoroquinolones. Enrofloxacin is metabolised in some animal species into ciprofloxacin, but enrofloxacin itself is designed for veterinary use.
Can enrofloxacin be used in humans? No. Enrofloxacin is approved for veterinary use only and is not intended for human treatment.
Which bacteria does enrofloxacin cover? It covers Mycoplasma, Escherichia coli, Salmonella, Pasteurella, Haemophilus, Staphylococcus aureus and several other Gram-negative and Gram-positive pathogens.
How does enrofloxacin kill bacteria? It inhibits bacterial DNA gyrase, blocking DNA replication and causing bacterial cell death.
Why is veterinary supervision required? To ensure correct diagnosis, appropriate dosing, compliance with withdrawal periods and responsible use that limits antimicrobial resistance.